Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

Tekijä Wong, Andrea L. A., Lee, Soo-Chin
Julkaistu 2012

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors

Tekijä Lee, Matilda, Hirpara, Jayshree L., Eu, Jie-Qing, Sethi, Gautam, Wang, Lingzhi, Goh, Boon-Cher, Wong, Andrea L.
Julkaisussa Redox Biol (2018)

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Tekijä Li, Jiaqi, Eu, Jie Qing, Kong, Li Ren, Wang, Lingzhi, Lim, Yaw Chyn, Goh, Boon Cher, Wong, Andrea L. A.
Julkaisussa Molecules (2020)

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance

Tekijä Hirpara, Jayshree, Eu, Jie Qing, Tan, Joanna Kia Min, Wong, Andrea L., Clement, Marie-Veronique, Kong, Li Ren, Ohi, Naoto, Tsunoda, Takeshi, Qu, Jianhua, Goh, Boon Cher, Pervaiz, Shazib
Julkaisussa Redox Biol (2018)

Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients

Tekijä Voon, Pei Jye, Yap, Hui Ling, Ma, Cho-Yee-Thu, Lu, Fan, Wong, Andrea L A, Sapari, Nur Sabrina, Soong, Richie, Soh, Thomas I P, Goh, Boon-Cher, Lee, How-Sung, Lee, Soo-Chin
Julkaistu 2013

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

Tekijä Wong, Andrea L.A., Sundar, Raghav, Wang, Ting-Ting, Ng, Thian-C, Zhang, Bo, Tan, Sing-Huang, Soh, Thomas I.P., Pang, Angela S.L., Tan, Chee-Seng, Ow, Samuel G.W., Wang, Lingzhi, Mogro, Jannet, Ho, Jingshan, Jeyasekharan, Anand D., Huang, Yiqing, Thng, Choon-Hua, Chan, Ching-Wan, Hartman, Mikael, Iau, Philip, Buhari, Shaik A., Goh, Boon-Cher, Lee, Soo-Chin
Julkaisussa Oncotarget (2016)